- Home
- CVAC vs FNA Comparison
CVAC vs FNA Comparison
Compare CVAC & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- FNA
- Stock Information
- Founded
- CVAC 2000
- FNA 2010
- Country
- CVAC Germany
- FNA United States
- Employees
- CVAC N/A
- FNA N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CVAC Health Care
- FNA Health Care
- Exchange
- CVAC Nasdaq
- FNA Nasdaq
- Market Cap
- CVAC 924.3M
- FNA 910.9M
- IPO Year
- CVAC 2020
- FNA 2021
- Fundamental
- Price
- CVAC $3.59
- FNA $13.00
- Analyst Decision
- CVAC Hold
- FNA Buy
- Analyst Count
- CVAC 3
- FNA 7
- Target Price
- CVAC $10.00
- FNA $15.20
- AVG Volume (30 Days)
- CVAC 1.2M
- FNA 2.0M
- Earning Date
- CVAC 11-12-2024
- FNA 02-27-2025
- Dividend Yield
- CVAC N/A
- FNA N/A
- EPS Growth
- CVAC N/A
- FNA N/A
- EPS
- CVAC N/A
- FNA N/A
- Revenue
- CVAC $70,565,734.00
- FNA $244,995,000.00
- Revenue This Year
- CVAC $742.57
- FNA $18.70
- Revenue Next Year
- CVAC N/A
- FNA $14.47
- P/E Ratio
- CVAC N/A
- FNA N/A
- Revenue Growth
- CVAC 75.11
- FNA 18.16
- 52 Week Low
- CVAC $2.22
- FNA $4.65
- 52 Week High
- CVAC $5.28
- FNA $14.79
- Technical
- Relative Strength Index (RSI)
- CVAC 45.89
- FNA 78.72
- Support Level
- CVAC $3.70
- FNA $10.11
- Resistance Level
- CVAC $4.09
- FNA $13.04
- Average True Range (ATR)
- CVAC 0.22
- FNA 0.44
- MACD
- CVAC -0.09
- FNA 0.18
- Stochastic Oscillator
- CVAC 12.05
- FNA 97.02
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.